Monash IVF Group Ltd (ASX: MVF) Share Price and News
Price
Movement
(20 mins delayed)
52 Week Range
-
1 Year Return
Monash IVF Group Ltd Chart and Price Data
Fundamentals Data provided by Morningstar.
Data provided by Morningstar.Share Price
Day Change
52 Week Range
-
Yesterday's Close
Today's Open
Days Range
-
Volume
Avg. Volume (1 month)
Turnover
as at 24 Feb 3:44pm
Monash IVF Group Ltd (ASX: MVF)
Latest News
Share Fallers
Why Brightstar, EVT, Monash IVF, and Pro Medicus shares are dropping today
Healthcare Shares
After soaring 40% in 2 weeks, this ASX All Ords healthcare stock has been downgraded
Share Fallers
Why Collins Foods, Monash IVF, Premier Investments, and Step One shares are tumbling today
Broker Notes
Analysts rate CBA and these popular ASX shares as sells
Share Gainers
Why Gentrack, Monash IVF, Pro Medicus, and Qube shares are racing higher today
Healthcare Shares
This Aussie fertility company has rejected a takeover bid from private equity
Broker Notes
Macquarie tips 54% upside for this beaten down ASX All Ords healthcare stock
Healthcare Shares
Monash IVF has named a new Managing Director to help right the ship
Healthcare Shares
Macquarie tips 46% upside for this ASX All Ords healthcare stock
Broker Notes
Expert tips more than 50% upside for this ASX All Ords healthcare stock
Small Cap Shares
These small cap ASX shares could rise 10% to 40%
Healthcare Shares
Does Macquarie rate Monash IVF shares a buy, hold, or sell post-results?
Frequently Asked Questions
-
Yes, Monash IVF Group has historically paid two fully franked shareholder dividends a year.
-
Monash IVF Group generally pays its shareholder dividends in April and October.
-
Monash IVF Group listed on the ASX on 26 June 2014.
Dividend Payment History Data provided by Morningstar.
| Ex-Date | Amount | Franking | Type | Payable |
|---|---|---|---|---|
| 06 Mar 2025 | $0.0260 | 100.00% | Interim | 11 Apr 2025 |
| 05 Sep 2024 | $0.0250 | 100.00% | Final | 11 Oct 2024 |
| 07 Mar 2024 | $0.0250 | 100.00% | Interim | 05 Apr 2024 |
| 07 Sep 2023 | $0.0220 | 100.00% | Final | 11 Oct 2023 |
| 08 Mar 2023 | $0.0220 | 100.00% | Interim | 06 Apr 2023 |
| 08 Sep 2022 | $0.0220 | 100.00% | Final | 07 Oct 2022 |
| 07 Mar 2022 | $0.0220 | 100.00% | Interim | 04 Apr 2022 |
| 09 Sep 2021 | $0.0210 | 100.00% | Final | 08 Oct 2021 |
| 09 Mar 2021 | $0.0210 | 100.00% | Interim | 07 Apr 2021 |
| 05 Mar 2020 | $0.0210 | 100.00% | Interim | 02 Oct 2020 |
| 05 Sep 2019 | $0.0300 | 100.00% | Final | 11 Oct 2019 |
| 06 Sep 2018 | $0.0260 | 100.00% | Final | 12 Oct 2018 |
| 08 Mar 2018 | $0.0340 | 100.00% | Interim | 06 Apr 2018 |
| 06 Sep 2017 | $0.0000 | 100.00% | Final | 13 Oct 2017 |
| 02 Mar 2017 | $0.0430 | 100.00% | Interim | 07 Apr 2017 |
| 06 Sep 2016 | $0.0450 | 100.00% | Final | 14 Oct 2016 |
| 08 Mar 2016 | $0.0400 | 100.00% | Interim | 08 Apr 2016 |
MVF ASX Announcements
An announcement is considered as "Price Sensitive" if it is thought that it may have an impact on the price of the security.
| Date | Announcement | Price Sensitive? | Time | No. of Pages | File Size |
|---|---|---|---|---|---|
| YesNo |
About Monash IVF Group Ltd
Monash IVF Group Ltd (ASX: MVF) is a specialist assisted reproductive services provider. The company offers fertility treatments and specialist diagnostic obstetric and gynaecological ultrasound services. Monash is among the leading providers of assisted reproductive services in Australia and Malaysia. It also has a cooperative agreement with a hospital in China.
MVF Share Price History Data provided by Morningstar.
| Date | Close | Change | % Change | Volume | Open | High | Low |
|---|---|---|---|---|---|---|---|
| 16 Jan 2026 | $0.75 | $0.00 | 0.00% | 525,359 | $0.75 | $0.76 | $0.74 |
| 15 Jan 2026 | $0.75 | $-0.01 | -1.32% | 719,689 | $0.76 | $0.76 | $0.75 |
| 14 Jan 2026 | $0.76 | $0.01 | 1.34% | 458,974 | $0.76 | $0.76 | $0.75 |
| 13 Jan 2026 | $0.75 | $-0.01 | -1.33% | 625,917 | $0.76 | $0.76 | $0.74 |
| 12 Jan 2026 | $0.75 | $0.00 | 0.00% | 1,050,040 | $0.76 | $0.76 | $0.74 |
| 09 Jan 2026 | $0.75 | $0.00 | 0.00% | 849,941 | $0.76 | $0.77 | $0.74 |
| 08 Jan 2026 | $0.75 | $0.00 | 0.00% | 319,797 | $0.75 | $0.76 | $0.74 |
| 07 Jan 2026 | $0.75 | $-0.01 | -1.32% | 369,742 | $0.76 | $0.77 | $0.75 |
| 06 Jan 2026 | $0.76 | $0.01 | 1.33% | 823,877 | $0.75 | $0.77 | $0.74 |
| 05 Jan 2026 | $0.75 | $0.00 | 0.00% | 683,042 | $0.75 | $0.76 | $0.74 |
| 02 Jan 2026 | $0.75 | $0.02 | 2.72% | 325,184 | $0.73 | $0.76 | $0.73 |
| 31 Dec 2025 | $0.74 | $-0.01 | -1.35% | 853,335 | $0.75 | $0.75 | $0.73 |
| 30 Dec 2025 | $0.74 | $0.01 | 1.37% | 384,962 | $0.74 | $0.75 | $0.73 |
| 29 Dec 2025 | $0.73 | $-0.01 | -1.36% | 590,514 | $0.72 | $0.74 | $0.72 |
| 24 Dec 2025 | $0.74 | $-0.08 | -9.76% | 4,097,960 | $0.70 | $0.74 | $0.69 |
| 23 Dec 2025 | $0.82 | $0.01 | 1.23% | 508,552 | $0.82 | $0.82 | $0.82 |
| 22 Dec 2025 | $0.82 | $0.00 | 0.00% | 478,395 | $0.82 | $0.82 | $0.82 |
| 19 Dec 2025 | $0.82 | $0.00 | 0.00% | 600,822 | $0.82 | $0.82 | $0.82 |
| 18 Dec 2025 | $0.82 | $-0.01 | -1.22% | 740,806 | $0.82 | $0.82 | $0.82 |
| 17 Dec 2025 | $0.82 | $0.01 | 1.23% | 540,250 | $0.82 | $0.83 | $0.82 |
Director Transactions Data provided by Morningstar.
| Date | Director | Type | Amount | Value | Notes |
|---|---|---|---|---|---|
| 29 Dec 2025 | Catherine (Cathy) Aston | Sell | 75,000 | $53,928 |
On-market trade.
|
Directors & Management Data provided by Morningstar.
| Name | Title | Start Date | Profile |
|---|---|---|---|
| Ms Zita Peach | Non-Executive Director | Oct 2016 |
Ms Peach has more than 25 years of commercial experience in the pharmaceutical, biotechnology, medical devices and health services industries, and has worked for industry players such as CSL Limited, Fresenius Kabi and Merck Sharp & Dohme, the Australian subsidiary of Merck Inc. She is a Non-executive Director of three private equity owned companies, Icon Group Pty Ltd, Vet Partners Pty Ltd and Nucleus Network Pty Ltd.
|
| Mr Richard Hugh Davis | Non-Executive ChairmanNon-Executive Director | Jun 2014 |
Mr Davis worked for InvoCare for 20 years until 2008. For most of that time, he held the position of CEO and managed the growth of that business through several ownership changes and over 20 acquisitions, including offshore in Singapore. Prior to InvoCare Limited, Richard worked as an accounting partner of Bird Cameron. He is member of Risk Committee.
|
| Dr Dwayne Crombie | Non-Executive Director | Nov 2025 |
Mr Crombie has spent his entire career working in various parts of the healthcare system in both New Zealand and Australia. His experience has spanned public hospital provision, community-based, mental health and disability services. It has also included funding of public health and disability services, aged care, private health insurance and private healthcare. Dwayne originally trained in medicine and specialised in public health before moving on to senior management roles. He worked for global healthcare organisation Bupa for more than 15 years in several Managing Director roles. Dwaynes current governance roles include Southern Cross Healthcare and Southern Cross Society, as well as being chair of Repromed New Zealand, an IVF Provider.
|
| Mr Neil John Broekhuizen | Non-Executive Director | Jun 2014 |
Mr Broekhuizen is the Joint Chief Executive Officer of Ironbridge. He has over 35 years of experience in the finance industry including 29 years in private equity with Investcorp and Bridgepoint in Europe and Ironbridge in Australia. He has sat on the Ironbridge Investment Committee since inception. He is member of Risk Committee.
|
| Dr Richard Charles Henshaw | Executive Director | Apr 2014 |
Dr Henshaw has practiced in the field of reproductive medicine since 1995. He worked as a Fertility Specialist for the Group and retired from clinical practice in August 2025. He has served on many national bodies, including RANZCOG Council, the IVF Medical Directors Group of Australia and New Zealand, and the Reproductive Technology Accreditation Committee.
|
| Ms Catherine Jane West | Non-Executive Director | Sep 2020 |
Ms West has over 25 years of legal, business affairs and strategy experience in customer focused businesses in the media, entertainment, telecommunications and medical sectors in Australia, the UK and Europe.
|
| Ms Catherine (Cathy) Ann Aston | Non-Executive Director | Feb 2024 |
Ms Aston is a Non executive Director/Chair of listed and unlisted entities covering technology, financial services, marketing services, health and government sectors across Australia and Asia. She has commercial background with executive roles in finance, marketing and strategy, including as CFO for Telstra International and Chief Executive Officer of a mobiles joint venture in Sri Lanka. She is currently a Non-executive Director of Macquarie Investment Management Ltd (Chair of the Audit, Risk and Compliance committee), IVE Group Ltd (Chair of the Audit and Risk Committee) and IMB Bank Ltd (Chair). She is Chair of Risk Committee.
|
| Ms Victoria Atkinson | Non-Executive Director | Jan 2026 |
--
|
| Mr Malik Jainudeen | Chief Financial OfficerCompany Secretary | Apr 2019 |
-
|
| Johannes Lagerwij | Asia Managing Director |
-
|
|
| Peggy North | Chief Corporate Shared Services Officer |
-
|
|
| Malik Jainudeen | Chief Financial OfficerCompany Secretary |
-
|
|
| Tedd Fuell | Chief Governance and Risk Officer |
-
|
|
| Thierry Panthier | Chief Information Officer |
-
|
|
| Rebecca Redden | Chief Operating Officer |
-
|
|
| Deirdre Zander Fox | Chief Scientific Officer |
-
|
|
| Luk Rombauts | Group Medical Director |
-
|
Top Shareholders Data provided by Morningstar.
| Name | Shares | Capital |
|---|---|---|
| Washington H Soul Pattinson And Company Limited | 37,767,969 | 9.69% |
| Argo Investments Limited | 28,381,705 | 7.28% |
| Citicorp Nominees Pty Limited | 27,642,111 | 7.09% |
| J P Morgan Nominees Australia Pty Limited | 27,637,494 | 7.09% |
| HSBC Custody Nominees (Australia) Limited | 21,532,960 | 5.53% |
| HSBC Custody Nominees (Australia) Limited A/C 2 | 9,141,392 | 2.35% |
| UBS Nominees Pty Ltd | 4,642,413 | 1.19% |
| BNP Paribas Nominees Pty Ltd | 4,123,674 | 1.06% |
| Masfen Securities Limited | 4,000,000 | 1.03% |
| J & P Chick Pty Limited | 3,930,000 | 1.01% |
| Creabird Pty Ltd | 2,650,000 | 0.68% |
| Neweconomy Com Au Nominees Pty Limited | 2,637,466 | 0.68% |
| BNP Paribas Nominees Pty Ltd i | 2,584,913 | 0.66% |
| Mr Troy Benjamin Ince & Mrs Nadine Julie Miller | 2,250,000 | 0.58% |
| Ippoliti Pty Ltd | 2,011,336 | 0.52% |
| Pacific Custodians Pty Limited | 2,007,027 | 0.52% |
| Netwealth Investments Limited | 1,705,141 | 0.44% |
| Mr Prashant Nadkarni | 1,461,484 | 0.38% |
| Gregg Property Holdings Pty Ltd | 1,317,300 | 0.34% |
| Mclachlan Future Fund Pty Ltd | 1,300,000 | 0.32% |